5th International Congress on Tissue Engineering & Regenerative Medicine

Thomas J. Webster’s (H index: 128) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has formed over a dozen companies who have numerous FDA approved medical products currently improving human health in over 30,000 patients. His technology is also being used in commercial products to improve sustainability and renewable energy. He is currently helping those companies and serves as a professor at Brown University, Saveetha University, Hebei University of Technology, UFPI, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies. Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,350 publications to his credit with over 66,000 citations. He was recently nominated for the Nobel Prize in Chemistry. Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S.

Dr. Mitra is a Tenured Professor of Biomedical Engineering with joint appointment in Mechanical Engineering at Florida Tech. He earned his BSME degree from Jadavpur University, Calcutta, India in 1991. He then earned his M.S. and Ph.D. degree in Mechanical Engineering from NYU School of Engineering in 1993 and 1996 respectively. He is a Fellow of American Society of Mechanical Engineers and American Society for Laser Medicine and Surgery. He is also Associate Editor of four journal in the areas of medical device, and tissue engineering. He has published more than 150 articles in peer reviewed journals and conference proceedings.

Dr. Kara E. McCloskey, PhD, is a Founding Professor at the University of California, Merced in the Chemical and Materials Engineering (CME) Department and Fellow with the American Institute of Medical and Biomedical Engineering (AIMBE). She received her degrees in Chemical Engineering from The Ohio State University and Biomedical Engineering Department at The Cleveland Clinic Foundation and was an NIH-NRSA postdoctoral fellow at Georgia Institute of Technology. Early in her career, Dr. McCloskey was awarded a New Faculty Award from the California Institute of Regenerative Medicine (CIRM) is the Program Directors for a CIRM-funded Training Program in Undergraduate Stem Cell Engineering and Biology (TUSCEB) and the UC Merced Shared Resource Facility (SRL). She has been Founder and Chair of Graduate Program in Biological Engineering and Small-scale Technologies (BEST) and Materials and Biomaterials Science and Engineering (MBSE), and lead developer for UCM’s new B.S. degree in Chemical Engineering. Dr. McCloskey has participated in numerous NSF-funded research centers (CREST-CCBM, STC-CEMB, STC-EBICS and ERC-TARDISS). She is known for her work in directing and characterizing endothelial cells (EC) from embryonic stem cells (ESCs) and induced-pluripotent stem (iPS) cells. She has co-authored over 50 peer-reviewed journal articles in areas from magnetic cell separation, stem cell differentiation, and tissue assembly and is currently focusing her efforts examining cell-material interactions for developing functional tissues.

Dr Darwin Eton is a Distinguished Fellow of the Society of Vascular Surgery. He graduated from the Massachusetts Institute of Technology (B.Sc, MSc.) in 1978 and New York University Medical School (M.D.) in 1982. He initiated this project in 1999 at University of Miami where he was Professor and Chief of Vascular Surgery. He continued the clinical work as Professor of Surgery at the University of Chicago. This project won the Cures Within Reach Award in 2016. The proceeds were used to fund a confirmatory study at University of Illinois at Chicago, where Dr Eton had a Voluntary Professor appointment in Surgery. He started Vasogenesis Inc (Boston MA), where he presently serves as the Chief Research and Medical Officer. He has authored 45 peer review publications, book chapters, and books in Vascular Surgery, and has been an invited speaker in USA and internationally.